These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1419644)

  • 1. Prognostic variables for the selection of patients with operable soft tissue sarcomas to be considered in adjuvant chemotherapy trials.
    Ravaud A; Bui NB; Coindre JM; Lagarde P; Tramond P; Bonichon F; Stöckle E; Kantor G; Trojani M; Chauvergne J
    Br J Cancer; 1992 Nov; 66(5):961-9. PubMed ID: 1419644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superficial soft tissue sarcomas (S-STS): a study of 367 patients from the French Sarcoma Group (FSG) database.
    Salas S; Stoeckle E; Collin F; Bui B; Terrier P; Guillou L; Trassard M; Ranchere-Vince D; Gregoire F; Coindre JM
    Eur J Cancer; 2009 Aug; 45(12):2091-102. PubMed ID: 19351580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the 7th and 8th version of the AJCC classification system for soft tissue sarcomas of extremities and trunk in patients with localised, intermediate or high-grade disease treated at European tertiary sarcoma centres.
    Smolle MA; van de Sande M; Hayes A; Bergovec M; Smith HG; Liegl-Atzwanger B; Tunn PU; Niethard M; Windhager R; Szkandera J; Leithner A
    Eur J Surg Oncol; 2021 Aug; 47(8):2182-2188. PubMed ID: 33865657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A staging system for soft-tissue sarcoma and its evaluation in relation to treatment.
    Tomita Y; Kuratsu S; Naka N; Uchida A; Ono K; Ohsawa M; Aozasa K
    Int J Cancer; 1994 Jul; 58(2):168-73. PubMed ID: 8026876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis following locally recurrent soft-tissue sarcoma. A staging system based on primary and recurrent tumour characteristics.
    Choong PF; Gustafson P; Willén H; Akerman M; Baldetrop B; Fernö M; Alvegård T; Rydholm A
    Int J Cancer; 1995 Jan; 60(1):33-7. PubMed ID: 7814149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors-A Scandinavian Sarcoma Group study (SSG XX).
    Sundby Hall K; Bruland ØS; Bjerkehagen B; Zaikova O; Engellau J; Hagberg O; Hansson L; Hagberg H; Ahlström M; Knobel H; Papworth K; Zemmler M; Goplen D; Bauer HCF; Eriksson M
    Eur J Cancer; 2018 Aug; 99():78-85. PubMed ID: 29929092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group.
    Coindre JM; Terrier P; Bui NB; Bonichon F; Collin F; Le Doussal V; Mandard AM; Vilain MO; Jacquemier J; Duplay H; Sastre X; Barlier C; Henry-Amar M; Macé-Lesech J; Contesso G
    J Clin Oncol; 1996 Mar; 14(3):869-77. PubMed ID: 8622035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: a study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931.
    Kasper B; Ouali M; van Glabbeke M; Blay JY; Bramwell VH; Woll PJ; Hohenberger P; Schöffski P
    Eur J Cancer; 2013 Jan; 49(2):449-56. PubMed ID: 22975215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in superficial adult soft tissue sarcomas: analysis of a series of 105 patients.
    Cany L; Stoeckle E; Coindre JM; Kantor G; Bonichon F; Bui BN
    J Surg Oncol; 1999 May; 71(1):4-9. PubMed ID: 10362084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of progression, not extent of tumour shrinkage, defines prognosis in soft-tissue sarcoma - An analysis of the EORTC 62012 study of the EORTC STBSG.
    Grünwald V; Litière S; Young R; Messiou C; Lia M; Wardelmann E; van der Graaf W; Gronchi A; Judson I;
    Eur J Cancer; 2016 Sep; 64():44-51. PubMed ID: 27323349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of staging systems for localized extremity soft tissue sarcoma.
    Wunder JS; Healey JH; Davis AM; Brennan MF
    Cancer; 2000 Jun; 88(12):2721-30. PubMed ID: 10870054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological response assessment following neoadjuvant isolated limb perfusion in patients with primary, localised, high-grade soft tissue sarcoma.
    Andreou D; Werner M; Pink D; Traub F; Schuler MK; Gosheger G; Jobke B; Reichardt P; Tunn PU
    Int J Hyperthermia; 2016; 32(2):159-64. PubMed ID: 26670477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant radiotherapy in retroperitoneal sarcomas. A Scandinavian Sarcoma Group study of 97 patients.
    Trovik LH; Ovrebo K; Almquist M; Haugland HK; Rissler P; Eide J; Engellau J; Monge OR; Nyhus AB; Elde IK; Jebsen NL
    Acta Oncol; 2014 Sep; 53(9):1165-72. PubMed ID: 25000415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial.
    Pasquali S; Colombo C; Pizzamiglio S; Verderio P; Callegaro D; Stacchiotti S; Martin Broto J; Lopez-Pousa A; Ferrari S; Poveda A; De Paoli A; Quagliuolo V; Jurado JC; Comandone A; Grignani G; De Sanctis R; Palassini E; Llomboart-Bosch A; Dei Tos AP; Casali PG; Picci P; Gronchi A
    Eur J Cancer; 2018 Apr; 93():28-36. PubMed ID: 29475197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of adjuvant chemotherapy in children and adolescents with surgically resected, high-risk adult-type soft tissue sarcomas.
    Ferrari A; Brecht IB; Koscielniak E; Casanova M; Scagnellato A; Bisogno G; Alaggio R; Cecchetto G; Catania S; Meazza C; Int-Veen C; Kirsch S; Dantonello T; Carli M; Treuner J
    Pediatr Blood Cancer; 2005 Aug; 45(2):128-34. PubMed ID: 15852434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of necrosis after neoadjuvant therapy for soft tissue sarcoma.
    Vaynrub M; Taheri N; Ahlmann ER; Yao C; Fedenko AN; Allison DC; Chawla SP; Menendez LR
    J Surg Oncol; 2015 Feb; 111(2):152-7. PubMed ID: 25175933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of soft tissue sarcomas in first isolated local recurrence: a retrospective study of 83 cases].
    Moureau-Zabotto L; Thomas L; Bui BN; Chevreau C; Stockle E; Martel P; Bonneviale P; Marques B; Coindre JM; Kantor G; Matsuda T; Delannes M
    Cancer Radiother; 2004 Oct; 8(5):279-87. PubMed ID: 15561593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register.
    Trovik CS; Bauer HC; Alvegård TA; Anderson H; Blomqvist C; Berlin O; Gustafson P; Saeter G; Wallöe A
    Eur J Cancer; 2000 Apr; 36(6):710-6. PubMed ID: 10762742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular DNA content and prognosis of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experience.
    Alvegard TA; Berg NO; Baldetorp B; Fernö M; Killander D; Ranstam J; Rydholm A; Akerman M
    J Clin Oncol; 1990 Mar; 8(3):538-47. PubMed ID: 2407813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neoadjuvant chemotherapy and combined conservative treatment of soft tissue sarcoma in the adult].
    Cany L; Bui NB; Stöckle E; Coindre JM; Kantor G; Ravaud A
    Bull Cancer; 1992; 79(11):1077-85. PubMed ID: 1302534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.